1998
DOI: 10.1007/978-94-011-4786-6_15
|View full text |Cite
|
Sign up to set email alerts
|

Historical reflections on cell culture engineering

Abstract: Cell culture engineering has enabled the commercial marketing of about a dozen human therapeutic products derived from rDNA technology and numerous monoclonal antibody products as well. A variety of technologies have proven useful in bringing products to the marketplace. Comparisons of the technologies available 15 years ago are contrasted with those available today. A number of improvements in unit operations have greatly improved the robustness of the processes during the past 15 years. Further evolution of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0
2

Year Published

2001
2001
2015
2015

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(12 citation statements)
references
References 6 publications
(3 reference statements)
0
10
0
2
Order By: Relevance
“…CHO cells are very robust in a number of culture conditions, have been used for the past 40 years, and therefore are very well characterized. A large number of proteins have been produced on CHO-based systems, such as tPA, Factor VIII, and interferon-γ (reviewed in ref 28), and there are many different strategies currently employed that involve the use of metabolic engineering in order to design a system that will incorporate the robust CHO nature with increased cell proliferation and the use of serum-and/or protein-free media. Such systems include the development of "super-CHO" that expresses IGF-1 and transferrin and has the ability to grow in totally protein-free media (29); "veggie-CHO", a cell line that grows in serum-free media in the absence of transferrin and IGF-1 that produces the recombinant protein Flt-3L (30); the multicistronic CHO cell lines that incorporate the p21-, p27-or p53-containing tetracyclinerepressible expression vectors or the p27-bcl XL -tricistronic system or the lac switch system for inducing p21 in NS0 and CHO cell lines, which all aim to increase cell proliferation, productivity, and decrease cell death (22,23,(31)(32)(33)(34).…”
Section: Discussionmentioning
confidence: 99%
“…CHO cells are very robust in a number of culture conditions, have been used for the past 40 years, and therefore are very well characterized. A large number of proteins have been produced on CHO-based systems, such as tPA, Factor VIII, and interferon-γ (reviewed in ref 28), and there are many different strategies currently employed that involve the use of metabolic engineering in order to design a system that will incorporate the robust CHO nature with increased cell proliferation and the use of serum-and/or protein-free media. Such systems include the development of "super-CHO" that expresses IGF-1 and transferrin and has the ability to grow in totally protein-free media (29); "veggie-CHO", a cell line that grows in serum-free media in the absence of transferrin and IGF-1 that produces the recombinant protein Flt-3L (30); the multicistronic CHO cell lines that incorporate the p21-, p27-or p53-containing tetracyclinerepressible expression vectors or the p27-bcl XL -tricistronic system or the lac switch system for inducing p21 in NS0 and CHO cell lines, which all aim to increase cell proliferation, productivity, and decrease cell death (22,23,(31)(32)(33)(34).…”
Section: Discussionmentioning
confidence: 99%
“…1,2 However, despite recent successes in developing stable cell lines, media and operating conditions. 1,3,4 CHO cell culture often suffers from poorly understood instability and perturbation issues. This probably originates from variability in raw materials, cell inoculums, and microenvironments within the bioreactor, etc.…”
Section: Introductionmentioning
confidence: 99%
“…Since then, the use of primary cell substrates, such as primary chicken embryo fibroblasts (CEFs), has greatly facilitated vaccine manufacturing (e.g. measles, and mumps) [11]. Primary cells were derived directly from an animal source and were not stored-or to a limited extent-as cell banks.…”
Section: Evolution Of Vaccine Production Techniquesmentioning
confidence: 99%